<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1967" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1967/" /><meta name="ncbi_pagename" content="Multiple Cutaneous and Mucosal Venous Malformations - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Multiple Cutaneous and Mucosal Venous Malformations - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Multiple Cutaneous and Mucosal Venous Malformations" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/05/17" /><meta name="citation_author" content="Laurence M Boon" /><meta name="citation_author" content="Miikka Vikkula" /><meta name="citation_pmid" content="20301733" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1967/" /><meta name="citation_keywords" content="VMCM" /><meta name="citation_keywords" content="VMCM" /><meta name="citation_keywords" content="Angiopoietin-1 receptor" /><meta name="citation_keywords" content="TEK" /><meta name="citation_keywords" content="Multiple Cutaneous and Mucosal Venous Malformations" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Multiple Cutaneous and Mucosal Venous Malformations" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Laurence M Boon" /><meta name="DC.Contributor" content="Miikka Vikkula" /><meta name="DC.Date" content="2018/05/17" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1967/" /><meta name="description" content="The condition multiple cutaneous and mucosal venous malformations (VMCM) is characterized by the presence of small, multifocal bluish cutaneous and/or mucosal venous malformations. They are usually present at birth. New lesions appear with time. Small lesions are usually asymptomatic; larger lesions can invade subcutaneous muscle and cause pain. Malignant transformation has not been reported." /><meta name="og:title" content="Multiple Cutaneous and Mucosal Venous Malformations" /><meta name="og:type" content="book" /><meta name="og:description" content="The condition multiple cutaneous and mucosal venous malformations (VMCM) is characterized by the presence of small, multifocal bluish cutaneous and/or mucosal venous malformations. They are usually present at birth. New lesions appear with time. Small lesions are usually asymptomatic; larger lesions can invade subcutaneous muscle and cause pain. Malignant transformation has not been reported." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1967/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/vmcm/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1967/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE895460E040AFF100000000065B02C6.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1967_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1967_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mmd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/men1/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1967_"><span class="title" itemprop="name">Multiple Cutaneous and Mucosal Venous Malformations</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: VMCM</div><p class="contrib-group"><span itemprop="author">Laurence M Boon</span>, MD, PhD and <span itemprop="author">Miikka Vikkula</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1967_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1967_ai__"><div class="contrib half_rhythm"><span itemprop="author">Laurence M Boon</span>, MD, PhD<div class="affiliation small">Center for Vascular Anomalies<br />Division of Plastic Surgery<br />Cliniques Universitaires Saint Luc &#x00026;<br />Universit&#x000e9; catholique de Louvain<br />Brussels, Belgium<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="eb.niavuolcu@noob.ecnerual" class="oemail">eb.niavuolcu@noob.ecnerual</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Miikka Vikkula</span>, MD, PhD<div class="affiliation small">Human Molecular Genetics<br />de Duve Institute<br />Universit&#x000e9; catholique de Louvain<br />Brussels, Belgium<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="eb.niavuolcu@alukkiv.akkiim" class="oemail">eb.niavuolcu@alukkiv.akkiim</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">September 18, 2008</span>; Last Update: <span itemprop="dateModified">May 17, 2018</span>.</p><p><em>Estimated reading time: 18 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="vmcm.Summary" itemprop="description"><h2 id="_vmcm_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The condition multiple cutaneous and mucosal venous malformations (VMCM) is characterized by the presence of small, multifocal bluish cutaneous and/or mucosal venous malformations. They are usually present at birth. New lesions appear with time. Small lesions are usually asymptomatic; larger lesions can invade subcutaneous muscle and cause pain. Malignant transformation has not been reported.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of VMCM is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with small, multifocal cutaneous and/or mucosal bluish-purple vascular malformations with slow blood flow on Doppler ultrasound AND/OR by the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TEK</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Sclerotherapy, alone or in combination with plastic and reconstructive surgery, is used depending on the size and location of the lesions. Low molecular-weight heparin (LMWH) should be administered prior to any invasive procedure. When the D-dimer level is elevated and the fibrinogen level is low, LMWH should be initiated one to two weeks before surgery and continued for two weeks post surgery; if the fibrinogen level is normal, LMWH can be initiated the day prior to surgery. If the lesions are painful and D-dimers are elevated, LMWH can also be used to treat the associated pain.</p><p><i>Prevention of secondary complications:</i> If the D-dimer level is greater than twice the normal range, LMWH should be initiated before any surgery to avoid disseminated intravascular coagulopathy.</p><p><i>Surveillance:</i> Clinical reevaluation of VMCM lesions annually and if symptoms arise; D-dimer levels should be measured every five years, if lesions become painful, and before any surgical and/or sclerotherapeutic procedure.</p><p><i>Agents/circumstances to avoid:</i> Contraceptive pills with high estrogen concentration.</p><p><i>Evaluation of relatives at risk:</i> Physical examination of at-risk neonates to identify those who can benefit from early treatment.</p><p><i>Pregnancy management:</i> D-dimer levels should be evaluated every one to three months during pregnancy (depending on the symptoms) and before delivery to adjust heparin therapy and to avoid abnormal bleeding during delivery.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>VMCM is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Most individuals diagnosed with VMCM have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; the proportion of cases caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is unknown; none has been reported to date. Each child of an individual with VMCM has a 50% chance of inheriting the pathogenic variant. Prenatal testing for pregnancies at increased risk is possible if the <i>TEK</i> pathogenic variant has been identified in an affected family member.</p></div></div><div id="vmcm.Diagnosis"><h2 id="_vmcm_Diagnosis_">Diagnosis</h2><div id="vmcm.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Multiple cutaneous and mucosal venous malformations (VMCM) <b>should be suspected</b> in individuals with the following clinical features, laboratory findings, and family history.</p><p><b>Clinical features.</b> Small, multifocal cutaneous and/or mucosal bluish-purple vascular malformations (see <a class="figpopup" href="/books/NBK1967/figure/vmcm.F1/?report=objectonly" target="object" rid-figpopup="figvmcmF1" rid-ob="figobvmcmF1">Figure 1</a>):</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figvmcmF1" co-legend-rid="figlgndvmcmF1"><a href="/books/NBK1967/figure/vmcm.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figvmcmF1" rid-ob="figobvmcmF1"><img class="small-thumb" src="/books/NBK1967/bin/vmcm-Image001.gif" src-large="/books/NBK1967/bin/vmcm-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndvmcmF1"><h4 id="vmcm.F1"><a href="/books/NBK1967/figure/vmcm.F1/?report=objectonly" target="object" rid-ob="figobvmcmF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Multifocal mucocutaneous venous malformations (marked by arrows) A. On the tongue</p></div></div><ul><li class="half_rhythm"><div>Lesions are soft and usually compressible.</div></li><li class="half_rhythm"><div>Ultrasound examination reveals saccular compressible venous-like cavities and Doppler confirms slow blood flow.</div></li></ul><p><b>Laboratory findings</b></p><ul><li class="half_rhythm"><div>D-dimer level is commonly elevated, in some cases three times the normal (i.e., &#x0003c;500 ng/mL) level.</div></li><li class="half_rhythm"><div>Fibrinogen level can be below the normal (i.e., 150-450 ng/mL) range in cases of severe chronic consumptive coagulopathy.</div></li></ul><p><b>Family history.</b> Consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance. Note: Lack of a known family history of VMCM does not preclude the diagnosis.</p></div><div id="vmcm.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of VMCM <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>:</p><ul><li class="half_rhythm"><div>With small, multifocal cutaneous and/or mucosal bluish-purple vascular malformations with slow blood flow on Doppler ultrasound; AND/OR</div></li><li class="half_rhythm"><div>By identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TEK</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1967/table/vmcm.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figvmcmTmoleculargenetictestingusedin" rid-ob="figobvmcmTmoleculargenetictestingusedin">Table 1</a>).</div></li></ul><p>Note: Biopsy is usually not necessary for diagnosis</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>TEK</i> is performed.</div><div class="half_rhythm">Note: Because VMCM occurs through a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> mechanism and gross deletions/duplications predicted to result in a loss of function have not been reported, <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is not indicated.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>TEK</i> and other genes of interest (see <a href="#vmcm.Differential_Diagnosis">Differential Diagnosis</a>) may be considered [<a class="bk_pop" href="#vmcm.REF.limaye.2015.914">Limaye et al 2015</a>]. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="vmcm.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Multiple Cutaneous and Mucosal Venous Malformations</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1967/table/vmcm.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vmcm.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_vmcm.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_vmcm.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_vmcm.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_vmcm.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TEK</i></td><td headers="hd_h_vmcm.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_vmcm.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~90%&#x000a0;<sup>5</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="vmcm.TF.1.1"><p class="no_margin">See <a href="/books/NBK1967/#vmcm.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="vmcm.TF.1.2"><p class="no_margin">See <a href="#vmcm.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="vmcm.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="vmcm.TF.1.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> is not indicated, as VMCM occurs through a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> mechanism.</p></div></dd><dt>5. </dt><dd><div id="vmcm.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#vmcm.REF.vikkula.1996.1181">Vikkula et al [1996]</a>, <a class="bk_pop" href="#vmcm.REF.calvert.1999.1279">Calvert et al [1999]</a>, <a class="bk_pop" href="#vmcm.REF.wouters.2010.414">Wouters et al [2010]</a></p></div></dd></dl></div></div></div></div></div><div id="vmcm.Clinical_Characteristics"><h2 id="_vmcm_Clinical_Characteristics_">Clinical Characteristics</h2><div id="vmcm.Clinical_Description"><h3>Clinical Description</h3><p>The most typical finding in multiple cutaneous and mucosal venous malformations (VMCM) is presence of small multifocal cutaneous and/or mucosal venous malformations of bluish color [<a class="bk_pop" href="#vmcm.REF.wouters.2008">Wouters et al 2008</a>, <a class="bk_pop" href="#vmcm.REF.dompmartin.2010.224">Dompmartin et al 2010</a>, <a class="bk_pop" href="#vmcm.REF.wouters.2010.414">Wouters et al 2010</a>, <a class="bk_pop" href="#vmcm.REF.boon.2011">Boon et al 2011</a>, <a class="bk_pop" href="#vmcm.REF.boon.2012">Boon &#x00026; Vikkula 2012</a>, <a class="bk_pop" href="#vmcm.REF.boon.2013">Boon &#x00026; Vikkula 2013</a>]. They are usually present at birth and increase in size as the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child grows. New lesions appear with time. The malformations range in size from 1 mm to 1 cm.</p><p>Small millimetric lesions are usually asymptomatic, but can be of aesthetic concern. They do not usually bleed or ulcerate. Larger lesions (up to a few centimeters in diameter) can invade subcutaneous muscles and cause pain.</p><p>The size, number, and localization of lesions vary within and between families. Often one individual in a family has more extensive lesions than other family members; conversely, some family members may have only a few small, clinically insignificant lesions (see <a href="#vmcm.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>). Lesions are randomly located throughout the body. In rare cases, they can affect the gastrointestinal and/or anal mucosa (in contrast to the oral mucosa, which is more typically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>) [<a class="bk_pop" href="#vmcm.REF.vikkula.1996.1181">Vikkula et al 1996</a>, <a class="bk_pop" href="#vmcm.REF.brouillard.2007">Brouillard &#x00026; Vikkula 2007</a>, <a class="bk_pop" href="#vmcm.REF.wouters.2010.414">Wouters et al 2010</a>, <a class="bk_pop" href="#vmcm.REF.boon.2012">Boon &#x00026; Vikkula 2012</a>].</p><p>Malignant transformation of the vascular malformations has not been reported.</p><p><b>D-dimer concentration.</b> More than 80% of individuals with multifocal VMCM have elevated D-dimer concentration (normal: &#x0003c;500 ng/mL) [<a class="bk_pop" href="#vmcm.REF.dompmartin.2008.873">Dompmartin et al 2008</a>, <a class="bk_pop" href="#vmcm.REF.dompmartin.2010.224">Dompmartin et al 2010</a>, <a class="bk_pop" href="#vmcm.REF.wouters.2010.414">Wouters et al 2010</a>, <a class="bk_pop" href="#vmcm.REF.boon.2011">Boon et al 2011</a>]. D-dimer concentration is elevated in about 40% of individuals with <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> VM and is normal in more than 95% of individuals with multifocal glomuvenous malformations (see <a href="#vmcm.Differential_Diagnosis">Differential Diagnosis</a>) [<a class="bk_pop" href="#vmcm.REF.dompmartin.2008.873">Dompmartin et al 2008</a>].</p><p>This coagulopathy is clinically asymptomatic unless the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual undergoes an intervention, such as a surgical procedure or sclerotherapy. If D-dimer concentration is higher than twice the normal range, excess pre- and/or postoperative bleeding is observed; it can be prevented by preoperative administration of low molecular weight heparin (LMWH).</p><p><b>Histologic findings.</b> Enlarged venous-like channels with walls of smooth muscle of variable thickness are observed [<a class="bk_pop" href="#vmcm.REF.vikkula.1996.1181">Vikkula et al 1996</a>]. The endothelium is flattened but continuous. If rounded mural cells (glomus cells) are observed, the diagnosis is glomuvenous malformation [<a class="bk_pop" href="#vmcm.REF.boon.2004.971">Boon et al 2004</a>, <a class="bk_pop" href="#vmcm.REF.brouillard.2005.e13">Brouillard et al 2005</a>, <a class="bk_pop" href="#vmcm.REF.brouillard.2008">Brouillard et al 2008</a>, <a class="bk_pop" href="#vmcm.REF.brouillard.2013.157">Brouillard et al 2013</a>] (see <a href="#vmcm.Differential_Diagnosis">Differential Diagnosis</a>).</p></div><div id="vmcm.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation has been reported [<a class="bk_pop" href="#vmcm.REF.wouters.2010.414">Wouters et al 2010</a>].</p></div><div id="vmcm.Penetrance"><h3>Penetrance</h3><p>Approximately 90% of individuals who have a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> variant in <i>TEK</i> develop mucocutaneous venous malformations by age 20 years; conversely, approximately 10% of individuals with a germline gain-of-function <i>TEK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are clinically unaffected [<a class="bk_pop" href="#vmcm.REF.boon.2004.971">Boon et al 2004</a>, <a class="bk_pop" href="#vmcm.REF.wouters.2010.414">Wouters et al 2010</a>]. Reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> can be explained by the need to acquire a second, somatic pathogenic gain-of-function variant in the wild type or the already mutated <i>TEK</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> in the target cell(s) to develop a lesion(s) [<a class="bk_pop" href="#vmcm.REF.limaye.2009.118">Limaye et al 2009</a>, <a class="bk_pop" href="#vmcm.REF.soblet.2017.207">Soblet et al 2017</a>].</p></div><div id="vmcm.Nomenclature"><h3>Nomenclature</h3><p>Terms used previously to describe venous malformation include "cavernous angioma" and sometimes "cavernous hemangioma."</p><p>The term mucocutaneous venous malformation was coined by <a class="bk_pop" href="#vmcm.REF.boon.1994.1583">Boon et al [1994]</a> for the lesions identified in a large multigenerational family from the US.</p><p>The abbreviation VMCM stands for inherited <i>v</i>enous <i>m</i>alformation <i>c</i>utaneous and <i>m</i>ucosal.</p></div><div id="vmcm.Prevalence"><h3>Prevalence</h3><p>The prevalence of VMCM is unknown; however, it accounts for fewer than 1% of individuals with venous anomalies followed in multidisciplinary centers specializing in vascular abnormalities [<a class="bk_pop" href="#vmcm.REF.boon.2004.971">Boon et al 2004</a>].</p></div></div><div id="vmcm.Genetically_Related_Disorders"><h2 id="_vmcm_Genetically_Related_Disorders_">Genetically Related Disorders</h2><p>VMCM and other <i>TEK</i>-mediated venous malformation disorders described below cover a spectrum of phenotypes of varying severity and models of mutation acquisition (reviewed by <a class="bk_pop" href="#vmcm.REF.soblet.2017.207">Soblet et al [2017]</a>). Each disorder is caused by <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> pathogenic variants that result in varying degrees of ligand-independent activation (constitutive activation) of TIE2, the protein product of <i>TEK</i> (see <a href="#vmcm.Molecular_Genetics">Molecular Genetics</a>). However, predisposition to the conditions listed below is not heritable because these variants are not present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>.</p><p><b>Blue rubber bleb nevus (BRBN) syndrome</b> (OMIM <a href="http://omim.org/entry/112200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">112200</a>) is characterized by small multifocal cutaneous and mucosal venous-like lesions. They are rubbery blebs, often round and hyperkeratotic. There is often one large venous malformation (VM) lesion ("dominant lesion") at birth with subsequent development of multiple small rubbery bluish palmar and plantar lesions. Multiple gastrointestinal VMs may also develop and can cause bleeding and severe chronic anemia. The BRBN <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> evolves much more over time than multifocal venous malformations (MVM) or VMCM. BRBN occurs sporadically.</p><p>BRBN is caused by somatic activating (<a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a>) pathogenic <i>TEK</i> variants [<a class="bk_pop" href="#vmcm.REF.soblet.2017.207">Soblet et al 2017</a>]; thus, they typically are not detectable in DNA from blood cells unless highly sensitive molecular techniques are used. Unlike VMCM-causing pathogenic variants, they typically occur on the same <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> (i.e., double [<a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a>] pathogenic variants [&#x0003e;83%]). The allele <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000459" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000459.4</a>: c.[3314C&#x0003e;A;3316A&#x0003e;C], <a href="https://www.ncbi.nlm.nih.gov/protein/NP_000450.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000450.2</a>:p.[(Thr1105Asn;Thr1106Pro)] is recurrent (57% of individuals with molecularly confirmed BRBN syndrome); the published nomenclature of the allele is T1105N-T1106P [<a class="bk_pop" href="#vmcm.REF.soblet.2017.207">Soblet et al 2017</a>]. The remainder are largely double (<i>cis</i>) pathogenic variants containing <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000459" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000459.4</a>:c.2690A&#x0003e;G (p.Tyr897Cys) with different combinations [<a class="bk_pop" href="#vmcm.REF.soblet.2013">Soblet et al 2013</a>, <a class="bk_pop" href="#vmcm.REF.soblet.2017.207">Soblet et al 2017</a>]. Interestingly, the same double (<i>cis</i>) pathogenic variants are seen in multiple lesions from the same individual, suggesting a common cellular ancestor for the lesions.</p><p><b>Multifocal venous malformation (MVM),</b> like VMCM, is characterized by multiple VMs all over the body, more commonly located on the skin, but (unlike BRBN) not on the palms and soles. Affected individuals can sometimes have gastrointestinal lesions. The VMs are often more subcutaneous than cutaneous. Individuals with MVM typically have fewer lesions than individuals with BRBN.</p><p>MVM is a <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> condition. Like BRBN, it is caused by double (<a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a>) pathogenic variants that occur on the same <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#vmcm.REF.soblet.2017.207">Soblet et al 2017</a>]. However, the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual typically acquires an initial mosaic activating pathogenic <i>TEK</i> variant (most commonly <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000459" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000459.4</a>: c.2743C&#x0003e;T (p.Arg915Cys) and subsequently acquires a second activating <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on the same allele (most commonly <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000459" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000459.4</a>:c.2690A&#x0003e;G (p.Tyr897Cys), a so-called "second-hit." The second-hit pathogenic variant may vary among lesions from the same individual. The haplotype of a pathogenic allele with the two most common variants would be designated as <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000459" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000459.4</a>:c.[2743C&#x0003e;T;2690A&#x0003e;G].</p><p><b>Venous malformation (VM)</b> is the most common type of venous anomaly. This unifocal vascular malformation occurs sporadically. In about 60% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> VM is caused by <i>somatic</i> pathogenic variants in <i>TEK</i>; the most common is an <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000459" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000459.4</a>: c.2740C&#x0003e;T (p.Leu914Phe) variant on one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#vmcm.REF.limaye.2009.118">Limaye et al 2009</a>, <a class="bk_pop" href="#vmcm.REF.soblet.2013">Soblet et al 2013</a>]. Somatic heterozygosity for this allele appears to provide sufficient <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> activity for lesion formation. For other causes of unifocal venous malformation, see <a href="#vmcm.Differential_Diagnosis">Differential Diagnosis</a>.</p></div><div id="vmcm.Differential_Diagnosis"><h2 id="_vmcm_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Glomuvenous malformations</b> (OMIM <a href="http://omim.org/entry/138000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">138000</a>), like multiple cutaneous and mucosal venous malformations (VMCM), are inherited multifocal, small cutaneous venous-like lesions, but they are not usually seen on mucous membranes. They have a cobblestone appearance [<a class="bk_pop" href="#vmcm.REF.boon.2004.971">Boon et al 2004</a>, <a class="bk_pop" href="#vmcm.REF.mallory.2006.892">Mallory et al 2006</a>, <a class="bk_pop" href="#vmcm.REF.brouillard.2013.157">Brouillard et al 2013</a>]. Glomuvenous malformations are deeper purple in color than VMCM, are painful on palpation, and are less invasive than <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> venous malformations. Most lesions are located on the extremities. Histologically, they are characterized by the presence of abnormal mural cells called "glomus cells."</p><p>Glomuvenous malformations are caused by <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> pathogenic variants in <i>GLMN</i> (encoding glomulin). Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>, although the pathophysiologic mechanism is recessive at the cellular level (i.e., disease caused by presence of a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> and an acquired <a class="def" href="/books/n/gene/glossary/def-item/somatic-pathogenic-variant/">somatic pathogenic variant</a> on the other allele), most frequently as a result of an acquired uniparental isodisomy [<a class="bk_pop" href="#vmcm.REF.brouillard.2002.866">Brouillard et al 2002</a>, <a class="bk_pop" href="#vmcm.REF.amyere.2013.188">Amyere et al 2013</a>].</p><p><b>Venous malformation (VM)</b> is caused by somatic <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic <i>PIK3CA</i> variants in about 20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Like <i>TEK</i> variants, these <i>PIK3CA</i> variants are <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> (activating) variants that result in constitutive activation of the downstream PI3K/AKT signaling pathway [<a class="bk_pop" href="#vmcm.REF.limaye.2015.914">Limaye et al 2015</a>]. See <a href="#vmcm.Genetically_Related_Disorders">Genetically Related Disorders</a>.</p></div><div id="vmcm.Management"><h2 id="_vmcm_Management_">Management</h2><div id="vmcm.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with multiple cutaneous and mucosal venous malformations (VMCM), the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>MRI of the affected area to evaluate extension into underlying tissue [<a class="bk_pop" href="#vmcm.REF.dompmartin.2010.224">Dompmartin et al 2010</a>, <a class="bk_pop" href="#vmcm.REF.boon.2011">Boon et al 2011</a>, <a class="bk_pop" href="#vmcm.REF.boon.2012">Boon &#x00026; Vikkula 2012</a>]</div></li><li class="half_rhythm"><div>Measurement of serum D-dimers and fibrinogen level to evaluate for chronic consumptive coagulopathy [<a class="bk_pop" href="#vmcm.REF.dompmartin.2008.873">Dompmartin et al 2008</a>].</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="vmcm.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Management depends largely on the size and location of the lesions. Treatment is required for any symptomatic VMCM lesion. Although sclerotherapy is the treatment of choice, sclerosing agents are not specific and can lead to ulceration if the VMCM is mucosal or involves the epidermis [<a class="bk_pop" href="#vmcm.REF.hammer.2001.595">Hammer et al 2001</a>, <a class="bk_pop" href="#vmcm.REF.dompmartin.2010.224">Dompmartin et al 2010</a>, <a class="bk_pop" href="#vmcm.REF.boon.2011">Boon et al 2011</a>]. Foam aethoxysclerol and bleomycin are preferentially used as sclerosing agents.</p><p>Surgery is effective for small lesions. For large VMs, surgical resection gives a better result if it is performed after sclerotherapy. Before any invasive procedure (i.e., surgery and/or sclerotherapy), low molecular weight heparin (LMWH) should be administered to reduce the bleeding risk. In the presence of an elevated D-dimer level and a low fibrinogen level, LMWH should be initiated one or two weeks before surgery, depending on the severity of the coagulation abnormality, and continued for two weeks after surgery. If the fibrinogen level is normal, LMWH can be initiated the day before surgery.</p><p>If lesions are painful and D-dimers are elevated, LMWH can be used to alleviate pain [<a class="bk_pop" href="#vmcm.REF.dompmartin.2008.873">Dompmartin et al 2008</a>]. Moreover, D-dimer levels can be used to evaluate the efficacy of both sclerotherapy and LMWH treatments, as levels will decrease with the lesion.</p></div><div id="vmcm.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>If VMCM is associated with localized intravascular coagulopathy (LIC) (i.e., D-dimer level &#x0003e;2x the normal range), treatment with low molecular-weight heparin should be initiated before any surgery in order to avoid perioperative decompensation of LIC into disseminated intravascular coagulopathy.</p></div><div id="vmcm.Surveillance"><h3>Surveillance</h3><p>Because VMCM lesions can increase in size over time and become painful or symptomatic, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals should be reevaluated yearly or whenever symptoms arise.</p><p>Measurements of serum D-dimers should be performed:</p><ul><li class="half_rhythm"><div>Every five years;</div></li><li class="half_rhythm"><div>If lesions become painful;</div></li><li class="half_rhythm"><div>Before any surgical and/or sclerotherapeutic procedure.</div></li></ul></div><div id="vmcm.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Contraceptive pills with high estrogen concentration should be avoided, as venous malformation lesions are estrogen responsive. Venous malformations can increase in size and become symptomatic, especially at initiation of estrogen-based contraception. (In some, but not all, instances, stabilization of a venous malformation lesion and diminution of pain may be observed after three months of contraceptive pill use.)</p></div><div id="vmcm.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Evaluating at-risk neonates by physical examination is appropriate in order to identify those who may benefit from early treatment.</p><p>Lesions arising after infancy usually stay small and therefore are rarely symptomatic. If no lesions are seen at birth, a second evaluation should be done around puberty.</p><p>If the <i>TEK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the family, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to evaluate at-risk relatives.</p><p>See <a href="#vmcm.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="vmcm.Pregnancy_Management"><h3>Pregnancy Management</h3><p>During pregnancy, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> women may develop new small lesions; in addition, existing lesions may increase in size and become painful.</p><p>If the D-dimer level is high, low molecular-weight heparin therapy may be used to alleviate pain.</p><p>D-dimer levels should be evaluated every one to three months during pregnancy depending on the symptoms and before delivery to adjust medication and to avoid abnormal bleeding during delivery.</p><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for further information on medication use during pregnancy.</p></div><div id="vmcm.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>A pilot study on rapamycin therapy for venous malformations has reported beneficial results, especially with regard to pain reduction and improvement in quality of life [<a class="bk_pop" href="#vmcm.REF.boscolo.2015.3491">Boscolo et al 2015</a>]. A Phase III clinical trial called VASE (<i>v</i>ascular <i>a</i>nomaly - <i>s</i>irolimus - <i>E</i>urope) has recently completed (<a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001703-32/FR" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EudraCT 2015-001703-32</a>).</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="vmcm.Genetic_Counseling"><h2 id="_vmcm_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="vmcm.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Multiple cutaneous and mucosal venous malformations (VMCM) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="vmcm.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with VMCM have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>The proportion of cases caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is unknown; to date none has been reported.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has clinical evidence of VMCM and the <i>TEK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. (Though theoretically possible, no instances of germline mosaicism have been reported.)</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with VMCM may appear to be negative because of a milder phenotypic presentation, incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents (i.e., testing for the <i>TEK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the proband and careful dermatologic evaluation) have been performed.</div></li><li class="half_rhythm"><div>Note: Somatic <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for <i>TEK</i> pathogenic variants causes either <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> multifocal venous malformations, <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> venous malformation, or blue rubber bleb nevus syndrome [<a class="bk_pop" href="#vmcm.REF.limaye.2015.914">Limaye et al 2015</a>, <a class="bk_pop" href="#vmcm.REF.soblet.2017.207">Soblet et al 2017</a>]; see <a href="#vmcm.Genetically_Related_Disorders">Genetically Related Disorders</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or known to have a <i>TEK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>If the <i>TEK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is presumed to be slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>If the parents have not been tested for the <i>TEK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> are still at increased risk for VMCM because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent (10% of individuals with a <i>TEK</i> pathogenic variant will not have findings of VMCM) or the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with VMCM has a 50% chance of inheriting the <i>TEK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>TEK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="vmcm.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#vmcm.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="vmcm.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>TEK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p><b>Imaging studies.</b> Prenatal diagnosis of VMCM using imaging studies such as Doppler ultrasonography and/or MRI has not been reported. The number and size of fetal lesions are variable and unpredictable. Doppler ultrasonography may be used to evaluate for fetal lesions in those fetuses at increased risk for VMCM but the small size of the lesions makes them difficult to detect.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="vmcm.Resources"><h2 id="_vmcm_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Foundation for Faces of Children</b></div><div>258 Harvard Street</div><div>#367</div><div>Brookline MA 02446-2904</div><div><b>Phone:</b> 617-355-8299</div><div><b>Email:</b> info@facesofchildren.org</div><div><a href="https://facesofchildren.org/glossary/vascular-malformations/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Vascular Malformations</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/multiple-cutaneous-and-mucosal-venous-malformations" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Multiple cutaneous and mucosal venous malformations</a></div></li><li class="half_rhythm"><div><b>Vascular Anomaly Patient Association (VASCAPA)</b></div><div>Avenue Hippocrate 75</div><div>Brussels B-1200</div><div>Belgium</div><div><b>Email:</b> info@vascapa.org</div><div><a href="http://www.vascapa.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.vascapa.org</a></div></li></ul></div><div id="vmcm.Molecular_Genetics"><h2 id="_vmcm_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="vmcm.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Multiple Cutaneous and Mucosal Venous Malformations: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1967/table/vmcm.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vmcm.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_vmcm.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_vmcm.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_vmcm.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_vmcm.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_vmcm.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_vmcm.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_vmcm.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7010" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TEK</i></a></td><td headers="hd_b_vmcm.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7010" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9p21<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_vmcm.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q02763" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Angiopoietin-1 receptor</a></td><td headers="hd_b_vmcm.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/TEK" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TEK database</a></td><td headers="hd_b_vmcm.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TEK" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TEK</a></td><td headers="hd_b_vmcm.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TEK[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TEK</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="vmcm.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="vmcm.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Multiple Cutaneous and Mucosal Venous Malformations (<a href="/omim/600195,600221" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1967/table/vmcm.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vmcm.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600195" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600195</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL; VMCM</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600221" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600221</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TEK TYROSINE KINASE, ENDOTHELIAL; TEK</td></tr></tbody></table></div></div><p><b>Gene structure.</b> The longest <i>TEK</i> transcript variant <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000459" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000459.4</a> has 23 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, transcript, and protein information, see <a href="/books/NBK1967/#vmcm.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Eight pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been reported (see <a class="figpopup" href="/books/NBK1967/table/vmcm.T.vmcmassociated_tek_pathogenic_var/?report=objectonly" target="object" rid-figpopup="figvmcmTvmcmassociatedtekpathogenicvar" rid-ob="figobvmcmTvmcmassociatedtekpathogenicvar">Table 2</a>; <a href="/books/NBK1967/#vmcm.molgen.TA">Table A</a>, <b>HGMD</b>). All pathogenic variants identified to date are located in the parts of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> coding for the tyrosine kinase domains of the angiopoietin-1 receptor (also known as TIE2). The c.2545C&#x0003e;T substitution was detected in six families [<a class="bk_pop" href="#vmcm.REF.vikkula.1996.1181">Vikkula et al 1996</a>, <a class="bk_pop" href="#vmcm.REF.wouters.2010.414">Wouters et al 2010</a>, <a class="bk_pop" href="#vmcm.REF.boon.2011">Boon et al 2011</a>].</p><div id="vmcm.T.vmcmassociated_tek_pathogenic_var" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>VMCM-Associated <i>TEK</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1967/table/vmcm.T.vmcmassociated_tek_pathogenic_var/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vmcm.T.vmcmassociated_tek_pathogenic_var_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_vmcm.T.vmcmassociated_tek_pathogenic_var_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_vmcm.T.vmcmassociated_tek_pathogenic_var_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_vmcm.T.vmcmassociated_tek_pathogenic_var_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_vmcm.T.vmcmassociated_tek_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2545C&#x0003e;T</td><td headers="hd_h_vmcm.T.vmcmassociated_tek_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg849Trp</td><td headers="hd_h_vmcm.T.vmcmassociated_tek_pathogenic_var_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000459" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000459<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_000450.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000450<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_vmcm.T.vmcmassociated_tek_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2690A&#x0003e;C</td><td headers="hd_h_vmcm.T.vmcmassociated_tek_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr897Ser</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The normal angiopoietin-1 receptor (TIE2) is a dimeric receptor tyrosine kinase mostly expressed on vascular endothelial cells. TIE2 binds the ligands angiopoietin 1, 2, and 4. Its function is important for endothelial cell proliferation, survival, and migration during angiogenesis, and later for vascular stability.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants of <i>TEK</i> have a gain of function that causes ligand-independent increased phosphorylation and can activate STAT1 signaling, in contrast to wild type <i>TEK</i> [<a class="bk_pop" href="#vmcm.REF.korpelainen.1999.1">Korpelainen et al 1999</a>, <a class="bk_pop" href="#vmcm.REF.limaye.2009.118">Limaye et al 2009</a>, <a class="bk_pop" href="#vmcm.REF.boon.2011">Boon et al 2011</a>]. PI3K-AKT-FOXO1 pathway is activated, leading to reduced PDGF-beta production [<a class="bk_pop" href="#vmcm.REF.uebelhoer.2013.3438">Uebelhoer et al 2013</a>]. Loss of the normal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> at the cellular level (i.e., presence of a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on one allele and an acquired somatic gain-of-function pathogenic variant on the other allele) may be the mechanism of disease, as demonstrated by the somatic "second hit" identified in one VMCM tissue [<a class="bk_pop" href="#vmcm.REF.limaye.2009.118">Limaye et al 2009</a>, <a class="bk_pop" href="#vmcm.REF.soblet.2017.207">Soblet et al 2017</a>.</p><p>Although all VMCM-associated pathogenic variants result in ligand-independent phosphorylation of TIE2, the levels of hyperphosphylation of <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> and somatic variants are variable [<a class="bk_pop" href="#vmcm.REF.wouters.2010.414">Wouters et al 2010</a>], which may contribute to the significant intra- and interfamilial variation. <a class="bk_pop" href="#vmcm.REF.uebelhoer.2013.3438">Uebelhoer et al [2013]</a> and <a class="bk_pop" href="#vmcm.REF.n_tynki.2015.6374">N&#x000e4;tynki et al [2015]</a> document variation by variant type on (e.g.,) phosphorylation, localization, trafficking, and cellular <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><div id="vmcm.Cancer_and_Benign_Tumors"><h3>Cancer and Benign Tumors</h3><p>See <a href="#vmcm.Genetically_Related_Disorders">Genetically Related Disorders</a> for BRBN, MVM, and unifocal (<a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a>) venous malformations caused by somatic <i>TEK</i> pathogenic variants. Because these variants are not present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>, predisposition to these venous malformations is not heritable.</p></div></div><div id="vmcm.References"><h2 id="_vmcm_References_">References</h2><div id="vmcm.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.amyere.2013.188">Amyere M, Aerts V, Brouillard P, McIntyre BA, Duhoux FP, Wassef M, Enjolras O, Mulliken JB, Devuyst O, Antoine-Poirel H, Boon LM, Vikkula M. Somatic uniparental isodisomy explains multifocality of glomuvenous malformations. <span><span class="ref-journal">Am J Hum Genet. </span>2013;<span class="ref-vol">92</span>:188–96.</span> [<a href="/pmc/articles/PMC3567282/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3567282</span></a>] [<a href="/pubmed/23375657" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23375657</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.boon.2011">Boon LM, Enjolras O, Mulliken JB, Vikkula M. Vascular malformations. In: Irvine A, Hoeger P, Yan A, eds. <em>Harper&#x02019;s Textbook of Pediatric Dermatology</em>. 3 ed. Wiley-Blackwell; 2011:112.1-112.24.</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.boon.2013">Boon LM, Vikkula M. Molecular genetics of vascular malformations. In: Mulliken JB, Burrown PE, Fishman SJ, eds. <em>Mulliken and Young&#x02019;s Vascular Anomalies: Hemangiomas and Malformations</em>. 2 ed. New York, NY: Oxford University Press; 2013:327-75.</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.boon.2004.971">Boon LM, Mulliken JB, Enjolras O, Vikkula M. Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities. <span><span class="ref-journal">Arch Dermatol. </span>2004;<span class="ref-vol">140</span>:971–6.</span> [<a href="/pubmed/15313813" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15313813</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.boon.1994.1583">Boon LM, Mulliken JB, Vikkula M, Watkins H, Seidman J, Olsen BR, Warman ML. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. <span><span class="ref-journal">Hum Mol Genet. </span>1994;<span class="ref-vol">3</span>:1583–7.</span> [<a href="/pubmed/7833915" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7833915</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.boon.2012">Boon LM, Vikkula M. Vascular anomalies. In: <em>Fitzpatrick's Dermatology in General Medicine</em>. 8 ed. New York, NY: McGraw-Hill Professional Publishing; 2012.</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.boscolo.2015.3491">Boscolo E, Limaye N, Huang L, Kang KT, Soblet J, Uebelhoer M, Mendola A, Natynki M, Seront E, Dupont S, Hammer J, Legrand C, Brugnara C, Eklund L, Vikkula M, Bischoff J, Boon LM. Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects. <span><span class="ref-journal">J Clin Invest. </span>2015;<span class="ref-vol">125</span>:3491–504.</span> [<a href="/pmc/articles/PMC4588237/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4588237</span></a>] [<a href="/pubmed/26258417" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26258417</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.brouillard.2002.866">Brouillard P, Boon LM, Mulliken JB, Ghassib&#x000e9; M, Warman ML, Tan OT, Olsen BR, Vikkula M. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas"). <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">70</span>:866–74.</span> [<a href="/pmc/articles/PMC379115/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC379115</span></a>] [<a href="/pubmed/11845407" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11845407</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.brouillard.2013.157">Brouillard P, Boon LM, Revencu N, Berg J, Dompmartin A, Dubois J, Garzon M, Holden S, Kangesu L, Labr&#x000e8;ze C, Lynch SA, McKeown C, Meskauskas R, Quere I, Syed S, Vabres P, Wassef M, Mulliken JB, Vikkula M., GVM Study Group.  Genotypes and phenotypes of 162 families with a glomulin mutation. <span><span class="ref-journal">Mol Syndromol. </span>2013;<span class="ref-vol">4</span>:157–64.</span> [<a href="/pmc/articles/PMC3666456/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3666456</span></a>] [<a href="/pubmed/23801931" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23801931</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.brouillard.2008">Brouillard P, Enjolras E, Boon LM, Vikkula M. Glomulin and glomuvenous malformation. In: Epstein CJ, Erickson RP, Wynshaw-Boris A, eds. <em>Inborn Errors of Development</em>. New York, NY: Oxford University Press; 2008.</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.brouillard.2005.e13">Brouillard P, Ghassib&#x000e9; M, Penington A, Boon LM, Dompmartin A, Temple IK, Cordisco M, Adams D, Piette F, Harper JI, Syed S, Boralevi F, Ta&#x000ef;eb A, Danda S, Baselga E, Enjolras O, Mulliken JB, Vikkula M. Four common glomulin mutations cause two thirds of glomuvenous malformations ("familial glomangiomas"): evidence for a founder effect. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:e13.</span> [<a href="/pmc/articles/PMC1735996/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735996</span></a>] [<a href="/pubmed/15689436" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15689436</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.brouillard.2007">Brouillard P, Vikkula M. Genetic causes of vascular malformations. Hum Mol Genet. 2007;16 Spec No. 2:R140-9. [<a href="/pubmed/17670762" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17670762</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.calvert.1999.1279">Calvert JT, Riney TJ, Kontos CD, Cha EH, Prieto VG, Shea CR, Berg JN, Nevin NC, Simpson SA, Pasyk KA, Speer MC, Peters KG, Marchuk DA. Allelic and locus heterogeneity in inherited venous malformations. <span><span class="ref-journal">Hum Mol Genet. </span>1999;<span class="ref-vol">8</span>:1279–89.</span> [<a href="/pubmed/10369874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10369874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.dompmartin.2008.873">Dompmartin A, Acher A, Dompmartin A, Acher A, Thibon P, Tourbach S, Hermans C, Deneys V, Pocock B, Lequerrec A, Labb&#x000e9; D, Barrellier M-T, Vanwijck R, Vikkula M, Boon LM. Association of localized intravascular coagulopathy with venous malformations. <span><span class="ref-journal">Arch Dermatol. </span>2008;<span class="ref-vol">144</span>:873–7.</span> [<a href="/pmc/articles/PMC5572565/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5572565</span></a>] [<a href="/pubmed/18645138" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18645138</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.dompmartin.2010.224">Dompmartin A, Vikkula M, Boon LM. Venous malformation: update on aetiopathogenesis, diagnosis and management. <span><span class="ref-journal">Phlebology. </span>2010;<span class="ref-vol">25</span>:224–35.</span> [<a href="/pmc/articles/PMC3132084/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3132084</span></a>] [<a href="/pubmed/20870869" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20870869</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.hammer.2001.595">Hammer FD, Boon LM, Mathurin P, Vanwijck RR. Ethanol sclerotherapy of venous malformations: evaluation of systemic ethanol contamination. <span><span class="ref-journal">J Vasc Interv Radiol. </span>2001;<span class="ref-vol">12</span>:595–600.</span> [<a href="/pubmed/11340138" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11340138</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.korpelainen.1999.1">Korpelainen EI, Karkkainen M, Gunji Y, Vikkula M, Alitalo K. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response. <span><span class="ref-journal">Oncogene. </span>1999;<span class="ref-vol">18</span>:1–8.</span> [<a href="/pubmed/9926914" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9926914</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.limaye.2015.914">Limaye N, Kangas J, Mendola A, Godfraind C, Schl&#x000f6;gel MJ, Helaers R, Eklund L, Boon LM, Vikkula M. <span><span class="ref-journal">Am J Hum Genet. </span>2015;<span class="ref-vol">97</span>:914–21. <a href="https://www.ncbi.nlm.nih.gov/pubmed/26637981" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Somatic Activating PIK3CA Mutations Cause Venous Malformation.</a></span> [<a href="/pmc/articles/PMC4678782/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4678782</span></a>] [<a href="/pubmed/26637981" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26637981</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.limaye.2009.118">Limaye N, Wouters V, Uebelhoer M, Tuominen M, Wirkkala R, Mulliken JB, Eklund L, Boon LM, Vikkula M. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:118–24.</span> [<a href="/pmc/articles/PMC2670982/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2670982</span></a>] [<a href="/pubmed/19079259" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19079259</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.mallory.2006.892">Mallory SB, Enjolras O, Boon LM, Rogers E, Berk DR, Blei F, Baselga E, Ros AM, Vikkula M. Congenital plaque-type glomuvenous malformations presenting in childhood. <span><span class="ref-journal">Arch Dermatol. </span>2006;<span class="ref-vol">142</span>:892–6.</span> [<a href="/pubmed/16847206" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16847206</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.n_tynki.2015.6374">N&#x000e4;tynki M, Kangas J, Miinalainen I, Sormunen R, Pietil&#x000e4; R, Soblet J, Boon LM, Vikkula M, Limaye N, Eklund L. <span><span class="ref-journal">Hum Mol Genet. </span>2015;<span class="ref-vol">24</span>:6374–89. <a href="https://www.ncbi.nlm.nih.gov/pubmed/26319232" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Common and specific effects of TIE2 mutations causing venous malformations.</a></span> [<a href="/pmc/articles/PMC4614705/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4614705</span></a>] [<a href="/pubmed/26319232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26319232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.soblet.2017.207">Soblet J, Kangas J, N&#x000e4;tynki M, Mendola A, Helaers R, Uebelhoer M, Kaakinen M, Cordisco M, Dompmartin A, Enjolras O, Holden S, Irvine AD, Kangesu L, L&#x000e9;aut&#x000e9;-Labr&#x000e8;ze C, Lanoel A, Lokmic Z, Maas S, McAleer MA, Penington A, Rieu P, Syed S, van der Vleuten C, Watson R, Fishman SJ, Mulliken JB, Eklund L, Limaye N, Boon LM, Vikkula M. <span><span class="ref-journal">J Invest Dermatol. </span>2017;<span class="ref-vol">137</span>:207–216. <a href="https://www.ncbi.nlm.nih.gov/pubmed/27519652" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Blue rubber bleb nevus (BRBN) syndrome is caused by somatic TEK (TIE2) mutations.</a></span> [<a href="/pubmed/27519652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27519652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.soblet.2013">Soblet J, Limaye N, Uebelhoer M, Boon LM, Vikkula M. Variable somatic TIE2 mutations in half of sporadic venous malformations. Mol Syndromol 2013;4:179e83. [<a href="/pmc/articles/PMC3666452/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3666452</span></a>] [<a href="/pubmed/23801934" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23801934</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.uebelhoer.2013.3438">Uebelhoer M, N&#x000e4;tynki M, Kangas J, Mendola A, Nguyen HL, Soblet J, Godfraind C, Boon LM, Eklund L, Limaye N, Vikkula M. Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB. <span><span class="ref-journal">Hum Mol Genet. </span>2013;<span class="ref-vol">22</span>:3438–48.</span> [<a href="/pmc/articles/PMC3736867/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3736867</span></a>] [<a href="/pubmed/23633549" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23633549</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.vikkula.1996.1181">Vikkula M, Boon LM, Carraway KL III, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB, Olsen BR. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. <span><span class="ref-journal">Cell. </span>1996;<span class="ref-vol">87</span>:1181–90.</span> [<a href="/pubmed/8980225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8980225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.wouters.2008">Wouters V, Boon LM, Vikkula M. TIE2 and cutaneomucosal venous malformation. In: Epstein CJ, Erickson RP, Wynshaw-Boris A, eds. <em>Inborn Errors of Development</em>. New York, NY: Oxford University Press; 2008.</div></li><li class="half_rhythm"><div class="bk_ref" id="vmcm.REF.wouters.2010.414">Wouters V, Limaye N, Uebelhoer M, Irrthum A, Boon LM, Mulliken JB, Enjolras O, Baselga E, Berg J, Dompmartin A, Ivarsson SA, Kangesu L, Lacassie Y, Teebi AS, Pennington A, Rieu P, Vikkula M. Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. <span><span class="ref-journal">Eur J Hum Genet. </span>2010;<span class="ref-vol">18</span>:414–20.</span> [<a href="/pmc/articles/PMC2841708/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2841708</span></a>] [<a href="/pubmed/19888299" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19888299</span></a>]</div></li></ul></div></div><div id="vmcm.Chapter_Notes"><h2 id="_vmcm_Chapter_Notes_">Chapter Notes</h2><div id="vmcm.Author_Notes"><h3>Author Notes</h3><p><a href="http://www.saintluc.be/hospitalisation/dpts-serv/vasc_anomalies/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Centre for Vascular Anomalies</a>, Cliniques Universitaires St Luc</p><p>Dr Vikkula, <a href="http://www.deduveinstitute.be/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">de Duve Institute</a></p></div><div id="vmcm.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>17 May 2018 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 January 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 August 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>18 September 2008 (me) Review posted live</div></li><li class="half_rhythm"><div>17 January 2008 (mv) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1967</span><span class="label">PMID: <a href="/pubmed/20301733" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301733</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mmd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/men1/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1967&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1967/?report=reader">PubReader</a></li><li><a href="/books/NBK1967/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1967" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1967" style="display:none" title="Cite this Page"><div class="bk_tt">Boon LM, Vikkula M. Multiple Cutaneous and Mucosal Venous Malformations. 2008 Sep 18 [Updated 2018 May 17]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1967/pdf/Bookshelf_NBK1967.pdf">PDF version of this page</a> (230K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#vmcm.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#vmcm.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#vmcm.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#vmcm.Genetically_Related_Disorders" ref="log$=inpage&amp;link_id=inpage">Genetically Related Disorders</a></li><li><a href="#vmcm.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#vmcm.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#vmcm.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#vmcm.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#vmcm.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#vmcm.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#vmcm.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7010[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TEK</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1967+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1474060" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1474060" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1474060" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1474060" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301470" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Cerebral Cavernous Malformation, Familial</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Cerebral Cavernous Malformation, Familial<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Morrison L, Akers A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301668" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hemophilia B</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hemophilia B<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Konkle BA, Huston H, Nakaya Fletcher S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301578" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hemophilia A</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hemophilia A<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Konkle BA, Huston H, Nakaya Fletcher S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301667" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Vascular Ehlers-Danlos Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Vascular Ehlers-Danlos Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Byers PH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21348050" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Capillary Malformation-Arteriovenous Malformation Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Capillary Malformation-Arteriovenous Malformation Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bayrak-Toydemir P, Stevenson D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301733" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301733" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0417cd75f66d18aa77d686">Multiple Cutaneous and Mucosal Venous Malformations - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Multiple Cutaneous and Mucosal Venous Malformations - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:15:41-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE895460E040AFF100000000065B02C6&amp;ncbi_session=CE895460E0417CD1_1627SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1967%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1967&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1967/&amp;ncbi_pagename=Multiple Cutaneous and Mucosal Venous Malformations - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE895460E0417CD1_1627SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>